Literature DB >> 15644703

Portopulmonary hypertension and hepatopulmonary syndrome: two different entities affecting pulmonary vasculature in liver disease.

Graciela Martinez-Pallí, Jaime Balust Vidal, J Beltrán, Pilar Taurà.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15644703     DOI： 10.1097/01.ccm.0000151051.73799.a1

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  2 in total

Review 1.  [Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].

Authors:  Kerstin Herzer; Felix Post; Ali Canbay; Guido Gerken
Journal:  Med Klin (Munich)       Date:  2011-01-16

2.  Low serum levels of alpha1 anti-trypsin (α1-AT) and risk of airflow obstruction in non-primary α1-AT-deficient patients with compensated chronic liver disease.

Authors:  Elizabeth Rodríguez-Romero; Juan Antonio Suárez-Cuenca; César Iván Elizalde-Barrera; Paul Mondragón-Terán; José Enrique Martínez-Hernández; Eduardo Gómez-Cortés; Rebeca Pérez-Cabeza de Vaca; Rolando E Hernández-Muñoz; Alberto Melchor-López; Nayeli Gabriela Jiménez-Saab
Journal:  Med Sci Monit       Date:  2015-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.